Foghorn Therapeutics Inc (FHTX)

Finanzdaten der Foghorn Therapeutics Inc-Aktie (FHTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	391.95%16.07	3.27	9.25	8.15	7.56
	0.15%24.88	24.84	33.13	26.65	28.65
Research and Development	1.45%18.52	18.26	22.05	20.00	21.79
Operating Income/Loss	59.19%-8.81	-21.57	-23.88	-18.50	-21.10
Nonoperating Income/Loss	4.95%1.61	1.70	2.21	2.65	3.16
	63.82%-7.19	-19.88	-21.66	-15.85	-17.94
Attributable To Parent	63.82%-7.19	-19.88	-21.66	-15.85	-17.94
Basic Average Shares	1.57%70.63	69.54	-	63.03	62.98
Diluted Average Shares	1.57%70.63	69.54	-	63.03	62.98
Basic Earnings Per Share	65.52%-0.10	-0.29	-	-0.25	-0.28
Diluted Earnings Per Share	65.52%-0.10	-0.29	-	-0.25	-0.28